Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA.
about
Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatQualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay.Performance Evaluation of the VERSANT HCV RNA Qualitative Assay by Using Transcription-Mediated AmplificationMulticenter Evaluation of the VERSANT HCV RNA Qualitative Assay for Detection of Hepatitis C Virus RNALaboratory Assays for Diagnosis and Management of Hepatitis C Virus InfectionAbbott RealTime Hepatitis C Virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV Assays for Prediction of Sustained Virological Response to Pegylated Interferon and Ribavirin in Chronic Hepatitis C PatientsInterpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CAnalytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen QuantificationThe Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection.Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification.Seronegative hepatitis C virus infection.Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future PerspectivesPrediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy.
P2860
Q27469977-F34FEF23-9CCD-4A7D-9F4D-303F306BAC73Q27471406-794358D2-CF6E-41C6-B100-32FCD9FAB94DQ27473324-5C89179C-0B17-481E-B705-989B072C877CQ27473336-B05CF437-840C-4732-BF01-7BD375C2C456Q27473492-FD8ACAA4-3999-44D6-B061-BDDD711927C3Q27487942-CF4C1EE2-1BC5-4BC0-B213-53E25D77A04CQ27490792-D6465114-3E88-479F-9E69-2897264AA795Q27491329-A7C6394A-E571-470E-B3E5-E6EB2D3A1E5BQ35759214-82AC4744-CE40-4043-AD35-B0DD20D4A315Q36506264-5804E4C6-71FC-4DAC-BF92-D6F9A89A70BFQ36689718-4C4DC143-8B26-4964-B23F-5BA160743D0DQ37631608-17B6D14C-626B-4840-9663-41FBA807C0ADQ37945171-749B1535-BCA4-4BDE-8819-CE6EBF1D32B2Q42979490-0AEDA633-8A6F-4B84-B7D9-742A71786189
P2860
Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Performance characteristics of ...... tion of hepatitis C virus RNA.
@en
Performance characteristics of ...... tion of hepatitis C virus RNA.
@nl
type
label
Performance characteristics of ...... tion of hepatitis C virus RNA.
@en
Performance characteristics of ...... tion of hepatitis C virus RNA.
@nl
prefLabel
Performance characteristics of ...... tion of hepatitis C virus RNA.
@en
Performance characteristics of ...... tion of hepatitis C virus RNA.
@nl
P2093
P2860
P356
P1476
Performance characteristics of ...... ction of hepatitis C virus RNA
@en
P2093
M Roggendorf
S Hoffmann
S O Viazov
P2860
P304
P356
10.1002/JCLA.1042
P577
2001-01-01T00:00:00Z